By Business/Source
Currency:USD
2025/FY
Stock NameRevenueRatio
Research and development for oncology-focused precision medicine218.71M100.00%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States218.71M100.00%